Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature
New drugs come not only with benefits but also with unexpected toxicities which need to be promptly recognized and managed. Starting from a scholar case of acute heart failure with preserved ejection fraction following the administration of trabectedin (ET-743, Yondelis®) in a patient with a metasta...
Guardado en:
Autores principales: | Julien Catherine, Christiane Jungels, Valerie Durieux, Coralie Deliens, Bogdan Grigoriu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/319c91c1a88040b99fa91a6f2b98a8ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
por: David S. Moura, et al.
Publicado: (2021) -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Eijiro Shimada, et al.
Publicado: (2021) -
Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
por: Li Min, et al.
Publicado: (2021) -
Rejuvenating the Aging Heart by Enhancing the Expression of the <i>Cisd2</i> Prolongevity Gene
por: Chi-Hsiao Yeh, et al.
Publicado: (2021) -
Functional dynamics of myocardial injury biomarkers production during acute isoprenaline treatment in rats
por: Gatarić Nina, et al.
Publicado: (2021)